ENALAPRILAT
- Product NDC
- 51662-1477
- 11-digit product format
- 516621477
- Labeler code
- 51662
- Product ID
- 51662-1477_12044a95-d04f-2681-e063-6394a90af8cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ENALAPRILAT
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA078687
- Marketing category
- ANDA
- Marketing start
- 2020-02-01
- Substance
- ENALAPRILAT
- Active strength
- 1.25 mg/mL
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ENALAPRILAT
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ENALAPRILAT | 1.25 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GV0O7ES0R3 |
| Rxcui | 1729200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1477-1 | ENALAPRILAT | 1 mL in 1 VIAL | INJECTION | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1477 | ENALAPRILAT INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240224_9d88f915-13dd-5463-e053-2a95a90a09bf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1477-1 | 51662147701 | 1 mL in 1 VIAL (51662-1477-1) | 1 ml | 2020-02-01 | 0000-00-00 | No | No | Current |